Too much medicine in older people? Deprescribing through shared decision making

Jesse Jansen(The University of Sydney), Kirsten McCaffery(New South Wales Department of Health), Vasi Naganathan(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Jenny Doust(Australian e-Health Research Centre), Jim Colvin, Carissa Bonner(The University of Sydney), Les Irwig(The University of Sydney), Aine Heaney, Brooke Nickel(The University of Sydney), Robin Turner(The University of Sydney), Stacy M. Carter(University of Wollongong)

BMJ

June 3, 2016

10.1136/bmj.i2893

Cited by 304

Related Papers

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

|The Lancet|2012|12k

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes

|Journal of Clinical Epidemiology|2012|1.2k

Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials

|BMJ|2015|577

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis

|BMJ Open|2016|527

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies

|Thrombosis and Haemostasis|2014|467